I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
O'Hear, Carol E.
43
results:
Search for persons
X
Format
Online (43)
Mediatypes
Articles (Online) (38)
Bookchapter (Online) (1)
OpenAccess-fulltext (4)
Sorted by: Relevance
Sorted by: Year
?
1
PI3K orchestration of the in vivo persistence of chimeric a..:
Zheng, Wenting
;
O'Hear, Carol E.
;
Alli, Rajshekhar
...
Leukemia. 32 (2018) 5 - p. 1157-1167 , 2018
Link:
https://doi.org/10.1038/..
?
2
Antibody Buffering of a Ligand in vivo:
O'Hear, Carol E.
;
Foote, Jefferson
;
Eisen, Herman N.
Proceedings of the National Academy of Sciences of the United States of America. 102 (2005) 1 - p. 40-44 , 2005
Link:
https://www.jstor.org/st..
?
3
Antibody buffering of a ligandin vivo:
O'Hear, Carol E.
;
Foote, Jefferson
Proceedings of the National Academy of Sciences. 102 (2004) 1 - p. 40-44 , 2004
Link:
https://doi.org/10.1073/..
?
4
PI3K orchestration of the in vivo persistence of chimeric a..:
Zheng, Wenting
;
O'Hear, Carol E
;
Alli, Rajshekhar
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943191/. , 2018
Link:
http://www.ncbi.nlm.nih...
?
5
Antibody buffering of a ligand in vivo:
O'Hear, Carol E
;
Foote, Jefferson
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC544049. , 2005
Link:
http://www.ncbi.nlm.nih...
?
6
Gemtuzumab ozogamicin can reduce minimal residual disease i..:
O'Hear, Carol
;
Inaba, Hiroto
;
Pounds, Stanley
...
Cancer. 119 (2013) 22 - p. 4036-4043 , 2013
Link:
https://doi.org/10.1002/..
?
7
Single-Agent Mosunetuzumab Shows Durable Complete Responses..:
Budde, Lihua E
;
Assouline, Sarit
;
Sehn, Laurie H
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824395/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
8
Gemtuzumab Ozogamicin Can Reduce Minimal Residual Disease i..:
O'Hear, Carol
;
Inaba, Hiroto
;
Pounds, Stanley
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2013
Link:
http://www.ncbi.nlm.nih...
?
9
High-Dose Chemotherapy With Autologous Stem-Cell Rescue In ..:
Eckstein, O.S.
;
O'Hear, C.E.
;
Chi, S.
..
Biology of Blood and Marrow Transplantation. 16 (2010) 2 - p. S247 , 2010
Link:
https://doi.org/10.1016/..
?
10
Poster: MDS-445 Magrolimab In Combination With Azacitidine ..:
Sallman, David
;
Malki, Monzr Al
;
Asch, Adam
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S151 , 2022
Link:
https://doi.org/10.1016/..
?
11
Poster: IBCL-249 Mosunetuzumab Monotherapy Is an Effective ..:
Budde, Elizabeth L
;
Sehn, Laurie H
;
Matasar, Matthew
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S173 , 2022
Link:
https://doi.org/10.1016/..
?
12
MDS-445 Magrolimab In Combination With Azacitidine for Pati..:
Sallman, David
;
Malki, Monzr Al
;
Asch, Adam
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S314-S315 , 2022
Link:
https://doi.org/10.1016/..
?
13
Oral Abstract: IBCL-249 Mosunetuzumab Monotherapy Is an Eff..:
Budde, Elizabeth L
;
Sehn, Laurie H
;
Matasar, Matthew
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S117 , 2022
Link:
https://doi.org/10.1016/..
?
14
IBCL-249 Mosunetuzumab Monotherapy Is an Effective and Well..:
Budde, Elizabeth L
;
Sehn, Laurie H
;
Matasar, Matthew
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S387 , 2022
Link:
https://doi.org/10.1016/..
?
15
Oral Abstract: MDS-445 Magrolimab In Combination with Azaci..:
Sallman, David
;
Malki, Monzr Al
;
Asch, Adam
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S115 , 2022
Link:
https://doi.org/10.1016/..
1-15